Barrington Research cut their target price on shares of Anika Therapeutics from $20.00 to $19.00 and...
Anika Therapeutics (NASDAQ:ANIK – Get Free Report) was downgraded by equities researchers at StockNe...
Anika Therapeutics ( NASDAQ:ANIK ) First Quarter 2025 Results Key Financial Results Revenue: US$26.2...
Anika Therapeutics Inc (ANIK) showcases strong commercial growth and strategic advancements despite ...